Head-to-head · Cost-Efficiency Index
Pallas Health vs Found Youth
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Pallas Health
Shoppers comfortable paying a quarter at a time who want the whole cost stated before signup, and who are not looking for a month-to-month exit.
Visit Pallas HealthFound Youth
Shoppers who want a choice of injections, microdose plans or needle-free sublingual drops from a small physician-founded shop, and who live in the continental U.S.
Visit Found YouthThe verdict
Pallas Health and Found Youth tie on the Cost-Efficiency Index at 74/100, so neither wins outright on the numbers, so choose on fit. Pallas Health: Shoppers comfortable paying a quarter at a time who want the whole cost stated before signup, and who are not looking for a month-to-month exit. Found Youth: Shoppers who want a choice of injections, microdose plans or needle-free sublingual drops from a small physician-founded shop, and who live in the continental U.S.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Pallas Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Pallas Health | Found Youth |
|---|---|---|
| Cost-Efficiency Index | 74/100 | 74/100 |
| Semaglutide / mo | $199/moAverage — Pallas's own figure for $597 billed every 12 weeks, its only cadence; $139 covers the first 4 weeks | $249/mo1-month term, compounded; $669 for 3 months or $1,259 for 6 months, each paid up front |
| Tirzepatide / mo | $299/moAverage — Pallas's own figure for $897 billed every 12 weeks, its only cadence; $179 covers the first 4 weeks | $329/mo1-month term, compounded; $849 for 3 months or $1,599 for 6 months, each paid up front |
| Semaglutide / yr (modeled) | $2,58713 × 4 wks | $2,988 |
| Tirzepatide / yr (modeled) | $3,88713 × 4 wks | $3,948 |
| Coverage | Most states | Continental U.S. only |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #79 | #82 |
Pallas Health
74/100Where the value is
- Both molecules are priced publicly, with the charged block stated rather than only a monthly average
- A genuinely reduced first cycle — $139 semaglutide and $179 tirzepatide for the first four weeks
- Runs a Spanish-language lander as well as the English site, which most of this field does not
The tradeoffs
- There is no monthly rung. The only cadence is a 12-week block paid up front — $597 or $897 — so the advertised 'per month' figure is arithmetic rather than a payment anyone makes
- A 12-week cycle is 4.33 charges a year, not 4, so a year costs more than four times the block
Found Youth
74/100Where the value is
- Every GLP-1 product is priced on its product page before you start, with one-, three- and six-month terms side by side
- Six GLP-1 formats: semaglutide and tirzepatide as weekly injections, microdose plans (from $149 and $199) and sublingual drops (from $229 and $249)
- Names its pharmacy, The Pharmacy Hub in Miami, a state-licensed 503A compounding pharmacy, with its address and phone number
The tradeoffs
- The three- and six-month terms are charged in one payment ($669 or $1,259 for semaglutide), and all sales are final, so a longer term can't be refunded if you stop
- Ships only to the continental U.S., so Alaska and Hawaii are out, and no state-by-state list is published
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.